Telomerase and oral cancer

Oral Oncology

Volumn 37, Issue 4, 2001, Pages 333-340

  Sumida, T ^a   Hamakawa, H ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

hTERT; Human telomerase reverse transcriptase; Oral squamous cell carcinoma; OSCC; Telomerase

Indexed keywords

RIBONUCLEOPROTEIN; TELOMERASE;

ANTINEOPLASTIC ACTIVITY; CANCER DIAGNOSIS; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME 3; DIAGNOSTIC VALUE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC ANALYSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOUTH CARCINOMA; MOUTH MUCOSA; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SQUAMOUS CELL CARCINOMA;

EID: 0035033705     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00132-9     Document Type: Short Survey

References (112)

1. Telomere loss: Mitotic clock or genetic time bomb?
2. A survey of telomerase activity in human cancer
3. Head and neck cancer
4. Telomere end-replication problem and cell aging
5. Structure and function of telomeres
6. Telomerases
7. Telomere length regulation
8. Increased telomere size in sperm cells of mammals with long terminal (TTAGGG)n arrays
9. Control of telomere length by the human telomeric protein TRF1
10. Control of human telomere length by TRF1 and TRF2
11. TRF2 protects human telomeres from end-to-end fusions
12. Identification of a specific telomere terminal transferase activity in tetrahymena extracts
13. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
14. Specific association of human telomerase activity with immortal cells and cancer
15. The RNA component of human telomerase
16. A mammalian telomerase-associated protein
17. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
18. Telomerase catalytic subunit homologs from fission yeast and human
19. The limited in vitro lifetime of human diploid cell strains
20. The two-stage mechanism controlling cellular senescence and immortalization
21. Defining the molecular mechanisms of human cell immortalization
22. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
23. Chronologic and physiologic age affect replicative life-span of fibroblasts from diabetic, prediabetic, and normal donors
24. Aging clock: The watchmaker's masterpiece
25. Extension of life-span by introduction of telomerase into normal human cells
26. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
27. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinoma
28. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
29. Expression profile of the putative catalytic subunit of the telomerase gene
30. Myc activates telomerase
31. Direct activation of TERT transcription by c-MYC
32. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
33. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
34. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
35. Induction of telomerase activity in v-myc-transformed avian cells
36. Telomerase activation by the E6 gene product of human papillomavirus type 16
37. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length
38. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
39. Creation of human tumour cells with defined genetic elements
40. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA
41. NF-kappaB regulates transcription of the mouse telomerase catalytic subunit
42. Estrogen activates telomerase
43. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region
44. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells
45. The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene
46. Identification of Mad as a repressor of the human telomerase hTERT gene
47. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1
48. Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells
49. Telomerase activity in human development is regulated by human telomerase reverse transcriptase hTERT transcription and by alternate splicing of hTERT transcripts
50. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase hTERT in normal and neoplastic ovary, endometrium and myometrium
51. Telomerase activity in esophageal carcinoma
52. Telomerase activity in gastric cancer
53. Telomerase activity in small-cell and non-small-cell lung cancers
54. Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers
55. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
56. Telomerase activity is associated with cell cycle deregulation in human breast cancer
57. Telomerase activity in human renal cell carcinoma
58. Telomerase activity is detected in pancreatic cancer but not in benign tumors
59. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: Correlation with grade, histology, and proliferative activity
60. Telomerase activity in normal and malignant hematopoietic cells
61. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
62. Telomerase activity in human endometrium
63. Detection of telomerase activity in malignant and non malignant skin conditions
64. Telomerase activity in premalignant and malignant lesions of human oral mucosa
65. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes
66. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine
67. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer
68. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma
69. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications
70. Telomerase activity: A potential marker of bladder transitional cell carcinoma in bladder washes
71. Telomerase activity for the preoperative diagnosis of pancreatic cancer
72. Detection of telomerase activity in oral lesions
73. Telomerase activity in pleural effusions: Diagnostic significance
74. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients
75. Telomerase activity in benign and malignant thyroid tumors
76. Telomerase activity in lesions of the thyroid: Application to diagnosis of clinical samples including fine-needle aspirates
77. Detection of telomerase activity in breast masses by fine-needle aspiration
78. Human telomerase reverse transcriptase hTERT gene expression in FNA samples from thyroid neoplasms
79. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
80. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines
81. Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts
82. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells
83. The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity
84. New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines
85. Inhibitory effect of a marine microalgal polysaccharide on the telomerase activity in K562 cells
86. Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture
87. Preclinical and clinical strategies for development of telomerase and telomere inhibitors
88. Current progress in the gene therapy of cancer
89. A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter
90. Essential role of mouse telomerase in highly proliferative organs
91. Longevity, stress response, and cancer in aging telomerase-deficient mice
92. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues
93. Telomerase activity in oral squamous cell carcinoma
94. Telomerase components as a diagnostic tool in human oral lesions
95. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis
96. Telomerase activity in oral and maxillofacial tumors
97. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma
98. Telomerase activation and cell proliferation during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis
99. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients
100. Leukoplakia: Molecular understanding of pre-malignant lesions and implications for clinical management
101. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: Chromosomal aberrations
102. Experimental production of lingual carcinoma in hamsters by local application of 9,10-dimethyl-1,2-benzanthracene
103. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis
104. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction
105. Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction
106. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix
107. Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer
108. Detection of circulating tumour cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique
109. Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy
110. A stem cell niche theory of intestinal crypt maintenance based on a study of somatic mutation in colonic mucosa
111. Epidermal keratinocyte self-renewal is dependent upon dermal integrity
112. Telomerase activity in normal human epithelial cells